A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-04-24

Study Completion Date

2015-04-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to perform an epidemiological survey of the adult population in Hungary to calculate the seroprevalence of pertussis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pertussis Immunization Programs in Low Income Countries

NCT02983487

Bordetella Pertussis, Whooping Cough

COMPLETED

Seroprevalence of Pertussis Among Healthy Children and Adolescents in Kazakhstan

NCT04779853

Pertussis

UNKNOWN

Pertussis Immunization Programs in Low Income Countries - Ivory Coast

NCT03388034

Bordetella Pertussis, Whooping Cough

COMPLETED

BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa

NCT07005726

Infant Morbidity Infant Mortality Non-Specific Effects of Vaccines +1 more

ENROLLING_BY_INVITATION PHASE4

Bordetella Pertussis Carriage in College-aged Students

NCT02215564

Carriage of Bordetella Pertussis

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The protocol posting was amended to correct the detailed title. Since a sample of blood will be collected from all subjects (outside of routine hospital procedure), the study does not meet GSK's definition of an observational study and hence the term "observational" was deleted from the detailed title.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pertussis Pertussis Vaccines

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study Group

Subjects, male and female, aged 18 years and above who had agreed to collection of blood sample.

Group Type OTHER

Blood sampling

Intervention Type PROCEDURE

A blood sample (2.5 mL) will be collected from all subjects

Data collection

Intervention Type OTHER

Active questioning

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood sampling

A blood sample (2.5 mL) will be collected from all subjects

Intervention Type PROCEDURE

Data collection

Active questioning

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who the investigator believes can and will comply with the requirements of the protocol.
* Written informed consent will be obtained from subjects prior to performing any study procedures.
* Males or females ≥ 18 years of age at the time of enrollment.
* Agreeing to collection of a blood sample for the study.